408 related articles for article (PubMed ID: 28148307)
21. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.
Knudtzen FC; Nilsson AC; Hovius JW; Skarphedinsson S
Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1461-1470. PubMed ID: 32172371
[TBL] [Abstract][Full Text] [Related]
22. Point-of-care testing for CXCL13 in Lyme neuroborreliosis.
Pietikäinen A; Oksi J; Hytönen J
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):226-228. PubMed ID: 29567125
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy).
Bremell D; Hagberg L
BMC Infect Dis; 2011 Aug; 11():215. PubMed ID: 21831262
[TBL] [Abstract][Full Text] [Related]
24. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid.
Liba Z; Kayserova J; Elisak M; Marusic P; Nohejlova H; Hanzalova J; Komarek V; Sediva A
J Neuroinflammation; 2016 Mar; 13(1):55. PubMed ID: 26941012
[TBL] [Abstract][Full Text] [Related]
25. Sublime diagnosis of Lyme neuroborreliosis.
Segal BM; Logigian EL
Neurology; 2005 Aug; 65(3):351-2. PubMed ID: 16087895
[No Abstract] [Full Text] [Related]
26. Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.
van Gorkom T; Voet W; van Arkel GHJ; Heron M; Hoeve-Bakker BJA; Notermans DW; Thijsen SFT; Kremer K
Microbiol Spectr; 2022 Jun; 10(3):e0006122. PubMed ID: 35404103
[TBL] [Abstract][Full Text] [Related]
27. The chemotactic cytokines in the cerebrospinal fluid of patients with neuroborreliosis.
Grygorczuk S; Czupryna P; Dunaj J; Moniuszko-Malinowska A; Świerzbińska R; Pancewicz S
Cytokine; 2021 Jun; 142():155490. PubMed ID: 33744829
[TBL] [Abstract][Full Text] [Related]
28. CXCL13 chemokine in pediatric and adult neuroborreliosis.
Wutte N; Berghold A; Löffler S; Zenz W; Daghofer E; Krainberger I; Kleinert G; Aberer E
Acta Neurol Scand; 2011 Nov; 124(5):321-8. PubMed ID: 21320077
[TBL] [Abstract][Full Text] [Related]
29. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.
Rupprecht TA; Pfister HW; Angele B; Kastenbauer S; Wilske B; Koedel U
Neurology; 2005 Aug; 65(3):448-50. PubMed ID: 16087912
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis - a pilot study.
Tjernberg I; Johansson M; Henningsson AJ
Clin Chem Lab Med; 2019 Nov; 57(12):2008-2018. PubMed ID: 31199760
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic mechanisms may play a role in the local immune response in the central nervous system in neuroborreliosis.
Nordberg M; Forsberg P; Johansson A; Nyman D; Jansson C; Ernerudh J; Ekerfelt C
J Neuroimmunol; 2011 Mar; 232(1-2):186-93. PubMed ID: 21056912
[TBL] [Abstract][Full Text] [Related]
32. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.
Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U
J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073
[TBL] [Abstract][Full Text] [Related]
33. Stimulated Immune Response by TruCulture
Ørbæk M; Gynthersen RMM; Mens H; Stenør C; Wiese L; Brandt C; Ostrowski SR; Nielsen SD; Lebech AM
Front Cell Infect Microbiol; 2021; 11():666037. PubMed ID: 34041044
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of Borrelia-specific IL-4- and IFN-gamma-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis.
Widhe M; Skogman BH; Jarefors S; Eknefelt M; Eneström G; Nordwall M; Ekerfelt C; Croner S; Bergström S; Forsberg P; Ernerudh J
Int Immunol; 2005 Oct; 17(10):1283-91. PubMed ID: 16176932
[TBL] [Abstract][Full Text] [Related]
35. Lyme neuroborreliosis with antibodies in cerebrospinal fluid but not in serum.
Zomer TP; Bruinsma R; van Samkar A; Vermeeren YM; Wieberdink RG; van Kooten B; van Bemmel T
Eur J Neurol; 2023 Mar; 30(3):741-744. PubMed ID: 36371644
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal Fluid Pleocytosis and Elevated C-X-C Motif Chemokine Ligand 13 Value Predict Lyme Borreliosis in Children With Facial Palsy.
Pöyhönen H; Lähdesmäki T; Hytönen J; Peltola V
Pediatr Infect Dis J; 2019 Dec; 38(12):1195-1198. PubMed ID: 31634297
[TBL] [Abstract][Full Text] [Related]
37. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid.
Strle F; Ruzić-Sabljić E; Cimperman J; Lotric-Furlan S; Maraspin V
Clin Infect Dis; 2006 Sep; 43(6):704-10. PubMed ID: 16912943
[TBL] [Abstract][Full Text] [Related]
38. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
Grygorczuk S; Zajkowska J; Swierzbińska R; Pancewicz S; Kondrusik M; Hermanowska-Szpakowicz T
Rocz Akad Med Bialymst; 2005; 50():173-8. PubMed ID: 16358960
[TBL] [Abstract][Full Text] [Related]
39. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.
Skogman BH; Croner S; Nordwall M; Eknefelt M; Ernerudh J; Forsberg P
Pediatr Infect Dis J; 2008 Dec; 27(12):1089-94. PubMed ID: 19008771
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid levels of the macrophage-specific biomarker sCD163 are diagnostic for Lyme neuroborreliosis: An observational cohort study.
Ørbæk M; Gynthersen RMM; Mens H; Brandt C; Stenør C; Wiese L; Andersen ÅB; Møller HJ; Lebech AM
Clin Chim Acta; 2023 Mar; 543():117299. PubMed ID: 36931585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
